
Ryan N. Henderson
Examiner (ID: 2057, Phone: (571)270-1430 , Office: P/3779 )
| Most Active Art Unit | 3795 |
| Art Unit(s) | 3739, 3795, 3779 |
| Total Applications | 931 |
| Issued Applications | 516 |
| Pending Applications | 102 |
| Abandoned Applications | 329 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 382841
[patent_doc_number] => 07306793
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2007-12-11
[patent_title] => 'Defective recombinant adenoviruses expressing cytokines for antitumor treatment'
[patent_app_type] => utility
[patent_app_number] => 10/940358
[patent_app_country] => US
[patent_app_date] => 2004-09-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 3315
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 100
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/306/07306793.pdf
[firstpage_image] =>[orig_patent_app_number] => 10940358
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/940358 | Defective recombinant adenoviruses expressing cytokines for antitumor treatment | Sep 12, 2004 | Issued |
Array
(
[id] => 852705
[patent_doc_number] => 07378086
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2008-05-27
[patent_title] => 'Retroviral vector having an ovalbumin promoter'
[patent_app_type] => utility
[patent_app_number] => 10/935905
[patent_app_country] => US
[patent_app_date] => 2004-09-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 13
[patent_no_of_words] => 8868
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 55
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/378/07378086.pdf
[firstpage_image] =>[orig_patent_app_number] => 10935905
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/935905 | Retroviral vector having an ovalbumin promoter | Sep 7, 2004 | Issued |
Array
(
[id] => 7194699
[patent_doc_number] => 20050193435
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-09-01
[patent_title] => 'Prolonged culturing of avian (chicken) primordial germ cells (PGCs) using specific growth factors, use thereof to produce chimeric avians (chickens)'
[patent_app_type] => utility
[patent_app_number] => 10/934751
[patent_app_country] => US
[patent_app_date] => 2004-09-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6063
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0193/20050193435.pdf
[firstpage_image] =>[orig_patent_app_number] => 10934751
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/934751 | Prolonged culturing of avian (chicken) primordial germ cells (PGCs) using specific growth factors, use thereof to produce chimeric avians (chickens) | Sep 2, 2004 | Abandoned |
Array
(
[id] => 5035318
[patent_doc_number] => 20070099857
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-05-03
[patent_title] => 'Methods and means for inhibiting fever'
[patent_app_type] => utility
[patent_app_number] => 10/570501
[patent_app_country] => US
[patent_app_date] => 2004-09-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 20
[patent_no_of_words] => 16235
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0099/20070099857.pdf
[firstpage_image] =>[orig_patent_app_number] => 10570501
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/570501 | Methods and means for inhibiting fever | Aug 31, 2004 | Abandoned |
Array
(
[id] => 5010429
[patent_doc_number] => 20070280908
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-12-06
[patent_title] => 'Treatment of diabetes with synthetic beta cells'
[patent_app_type] => utility
[patent_app_number] => 10/923924
[patent_app_country] => US
[patent_app_date] => 2004-08-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 8075
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0280/20070280908.pdf
[firstpage_image] =>[orig_patent_app_number] => 10923924
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/923924 | Treatment of diabetes with synthetic beta cells | Aug 22, 2004 | Abandoned |
Array
(
[id] => 5252758
[patent_doc_number] => 20070134214
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-06-14
[patent_title] => 'Inactivated host cell delivery of polynucleotides encoding immunogens'
[patent_app_type] => utility
[patent_app_number] => 10/567940
[patent_app_country] => US
[patent_app_date] => 2004-08-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6983
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0134/20070134214.pdf
[firstpage_image] =>[orig_patent_app_number] => 10567940
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/567940 | Inactivated host cell delivery of polynucleotides encoding immunogens | Aug 11, 2004 | Abandoned |
Array
(
[id] => 17266385
[patent_doc_number] => 11191789
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-12-07
[patent_title] => Cartilage and bone repair and regeneration using postpartum-derived cells
[patent_app_type] => utility
[patent_app_number] => 10/876998
[patent_app_country] => US
[patent_app_date] => 2004-06-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 47971
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 49
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 10876998
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/876998 | Cartilage and bone repair and regeneration using postpartum-derived cells | Jun 24, 2004 | Issued |
Array
(
[id] => 7322123
[patent_doc_number] => 20040226058
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-11-11
[patent_title] => 'Prolonged culturing of avian (chicken) primordial germ cells (PGCs) using specific growth factors, use thereof to produce chimeric avians (chickens)'
[patent_app_type] => new
[patent_app_number] => 10/870805
[patent_app_country] => US
[patent_app_date] => 2004-06-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6325
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 3
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0226/20040226058.pdf
[firstpage_image] =>[orig_patent_app_number] => 10870805
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/870805 | Prolonged culturing of avian (chicken) primordial germ cells (PGCs) using specific growth factors, use thereof to produce chimeric avians (chickens) | Jun 17, 2004 | Abandoned |
Array
(
[id] => 397538
[patent_doc_number] => 07294507
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2007-11-13
[patent_title] => 'Ovomucoid promoters and methods of use'
[patent_app_type] => utility
[patent_app_number] => 10/856218
[patent_app_country] => US
[patent_app_date] => 2004-05-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 18
[patent_no_of_words] => 27605
[patent_no_of_claims] => 42
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 34
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/294/07294507.pdf
[firstpage_image] =>[orig_patent_app_number] => 10856218
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/856218 | Ovomucoid promoters and methods of use | May 27, 2004 | Issued |
Array
(
[id] => 6983372
[patent_doc_number] => 20050153442
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-07-14
[patent_title] => 'Adipose-derived stem cells and lattices'
[patent_app_type] => utility
[patent_app_number] => 10/845315
[patent_app_country] => US
[patent_app_date] => 2004-05-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 84
[patent_figures_cnt] => 84
[patent_no_of_words] => 86000
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0153/20050153442.pdf
[firstpage_image] =>[orig_patent_app_number] => 10845315
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/845315 | Adipose-derived stem cells and lattices | May 11, 2004 | Abandoned |
| 10/843704 | Novel murine polynucleotide sequences and mutant cells and mutant animals defined thereby | May 10, 2004 | Abandoned |
Array
(
[id] => 849194
[patent_doc_number] => 07381712
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2008-06-03
[patent_title] => 'In vivo transfection in avians'
[patent_app_type] => utility
[patent_app_number] => 10/842606
[patent_app_country] => US
[patent_app_date] => 2004-05-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11634
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 69
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/381/07381712.pdf
[firstpage_image] =>[orig_patent_app_number] => 10842606
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/842606 | In vivo transfection in avians | May 9, 2004 | Issued |
Array
(
[id] => 5701972
[patent_doc_number] => 20060218657
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-09-28
[patent_title] => 'Method for improving germline transmission efficiency of avian primordial germ cells'
[patent_app_type] => utility
[patent_app_number] => 10/554030
[patent_app_country] => US
[patent_app_date] => 2004-04-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 4734
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0218/20060218657.pdf
[firstpage_image] =>[orig_patent_app_number] => 10554030
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/554030 | Method for improving germline transmission efficiency of avian primordial germ cells | Apr 20, 2004 | Issued |
Array
(
[id] => 169199
[patent_doc_number] => 07667089
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-02-23
[patent_title] => 'Transgenic mammal secreting B-domain deleted human FVII in its milk'
[patent_app_type] => utility
[patent_app_number] => 10/820777
[patent_app_country] => US
[patent_app_date] => 2004-04-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 21
[patent_no_of_words] => 7585
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 89
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/667/07667089.pdf
[firstpage_image] =>[orig_patent_app_number] => 10820777
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/820777 | Transgenic mammal secreting B-domain deleted human FVII in its milk | Apr 8, 2004 | Issued |
Array
(
[id] => 5421969
[patent_doc_number] => 20090148424
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-06-11
[patent_title] => 'Reversibly immortalized mammalian liver cells and use thereof'
[patent_app_type] => utility
[patent_app_number] => 10/594544
[patent_app_country] => US
[patent_app_date] => 2004-03-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 8925
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0148/20090148424.pdf
[firstpage_image] =>[orig_patent_app_number] => 10594544
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/594544 | Reversibly immortalized mammalian liver cells and use thereof | Mar 30, 2004 | Abandoned |
Array
(
[id] => 7251949
[patent_doc_number] => 20040259130
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-12-23
[patent_title] => 'Transgenesis of early embyonic cells'
[patent_app_type] => new
[patent_app_number] => 10/812248
[patent_app_country] => US
[patent_app_date] => 2004-03-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 16603
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 10
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0259/20040259130.pdf
[firstpage_image] =>[orig_patent_app_number] => 10812248
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/812248 | Transgenesis of early embyonic cells | Mar 28, 2004 | Abandoned |
Array
(
[id] => 7264989
[patent_doc_number] => 20040242525
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-12-02
[patent_title] => 'Method for promoting gonadal growth in an animal'
[patent_app_type] => new
[patent_app_number] => 10/807377
[patent_app_country] => US
[patent_app_date] => 2004-03-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 3861
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0242/20040242525.pdf
[firstpage_image] =>[orig_patent_app_number] => 10807377
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/807377 | Method for promoting gonadal growth in an animal | Mar 23, 2004 | Abandoned |
Array
(
[id] => 7248011
[patent_doc_number] => 20040158885
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-08-12
[patent_title] => 'Chronic hepatitis virus infection and clonal hepatocellular carcinoma in mouse repopulated livers'
[patent_app_type] => new
[patent_app_number] => 10/805653
[patent_app_country] => US
[patent_app_date] => 2004-03-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 8318
[patent_no_of_claims] => 47
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 63
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0158/20040158885.pdf
[firstpage_image] =>[orig_patent_app_number] => 10805653
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/805653 | Chronic hepatitis virus infection and clonal hepatocellular carcinoma in mouse repopulated livers | Mar 18, 2004 | Abandoned |
Array
(
[id] => 7149954
[patent_doc_number] => 20040171146
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-09-02
[patent_title] => 'Adipose-derived stem cells and lattices'
[patent_app_type] => new
[patent_app_number] => 10/797371
[patent_app_country] => US
[patent_app_date] => 2004-03-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9824
[patent_no_of_claims] => 79
[patent_no_of_ind_claims] => 38
[patent_words_short_claim] => 11
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0171/20040171146.pdf
[firstpage_image] =>[orig_patent_app_number] => 10797371
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/797371 | Adipose-derived stem cells and lattices | Mar 8, 2004 | Abandoned |
Array
(
[id] => 7276318
[patent_doc_number] => 20040235769
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-11-25
[patent_title] => 'Anti-tumor effects of prostage Carcinoma Tumor Antigen-1'
[patent_app_type] => new
[patent_app_number] => 10/795927
[patent_app_country] => US
[patent_app_date] => 2004-03-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 19
[patent_no_of_words] => 15801
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 3
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0235/20040235769.pdf
[firstpage_image] =>[orig_patent_app_number] => 10795927
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/795927 | Anti-tumor effects of prostage Carcinoma Tumor Antigen-1 | Mar 7, 2004 | Abandoned |